Phase 3 study of Dimebon and donepezil combination therapy for Alzheimer's disease - MPR
Links shared publicly online about this topic.
- 2,114total visits
Phase 3 study of Dimebon and donepezil combination therapy for Alzheimer's disease - MPR
empr.com —
Pfizer and Medivation, Inc announced the initiation of a 12-month, Phase 3 trial of the investigational drug Dimebon in combination with donepezil HCl for the treatment of mild-to-moderate Alzheimer's disease (AD).
View full resource at empr.com
Tags: Alzheimer's Disease, Alzheimer's Disease Medication, Disease and Condition, Phase 3 Clinical Trial, Aricept, News, disease
Most Recently Shared on April 15, 2009 at 6:52 pm By:
MPR News: Phase 3 study of Dimebon and donepezil combination therapy for Alzheimer's disease: Pfizer an.. http://tinyurl.com/ddhqxg
Advertisement
